Skip to main content
Top

Current Cardiology Reports

Issue 6/2017

Content (10 Articles)

Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Evangelos C. Rizos, Moses S. Elisaf

Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Ian M. Graham, Alberico L. Catapano

Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Morton Leibowitz, Chandra Cohen-Stavi, Sanjay Basu, Ran D. Balicer

Transition of Care in Congenital Heart Disease: Ensuring the Proper Handoff

  • Congenital Heart Disease (RA Krasuski, Section Editor)

Angela Lee, Barbara Bailey, Geraldine Cullen-Dean, Sandra Aiello, Joanne Morin, Erwin Oechslin

Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease

  • Congenital Heart Disease (RA Krasuski, Section Editor)

Saurabh Rajpal, Laith Alshawabkeh, Alexander R. Opotowsky

The Vascular Wall: a Plastic Hub of Activity in Cardiovascular Homeostasis and Disease

  • Regenerative Medicine (SM Wu, Section Editor)

Cassandra P. Awgulewitsch, Linh T. Trinh, Antonis K. Hatzopoulos

Management of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective

  • Cardio-Oncology (SA Francis, Section Editor)

Dana Elena Giza, Kostas Marmagkiolis, Elie Mouhayar, Jean-Bernard Durand, Cezar Iliescu

Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes

  • Management of Acute Coronary Syndromes (AS Jaffe, Section Editor)

Jeffrey W. Meeusen, Leslie J. Donato, Allan S. Jaffe

Endovascular Management of Massive and Submassive Acute Pulmonary Embolism: Current Trends in Risk Stratification and Catheter-Directed Therapies

  • Peripheral Vascular Disease (CJ Cooper and R Gupta, Section Editors)

Ethan C. Kosova, Kush R. Desai, Daniel R. Schimmel

Exploring the Pathophysiology of Takotsubo Cardiomyopathy

  • Nuclear Cardiology (V Dilsizian, Section Editor)

Wengen Chen, Vasken Dilsizian

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME